The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
200 jobs Number of planned job losses
Announcement Date
8 February 2016
Employment effect (start)
Foreseen end date
31 March 2016
Description
British Group GlaxoSmithKline (GSK) is to close its local factory Europharm in Brasov in March 2016. As a result 200 employees will lose their job. The group announced that the redundant employees will receive severance packages and support to find a new job. Some of the production may be transferred to Spain and Poland.
GSK had announced last year its intention to sell the plant due to over-production in the solid oral formulas.
The plant was set up in 1994 and manufactured drugs for the treatment of HIV/AIDS, respiratory disease, depression, the flu/anti-inflammatory. Later in 1996 the British Group acquired 65% stake in the Romanian factory and the remainder 35% in 2003.
Sources
12 June 2014: România Liberă
29 September 2015: bizbrasov.ro
8 February 2016: Ziarul Financiar
Citation
Eurofound (2016), Europharm, Closure in Romania, factsheet number 86507, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/86507.